From: Nonalcoholic fatty liver disease and the risk of insulin-requiring gestational diabetes
Events (n) | Incidence rate* | Model 1 | Model 2 | Model 3 | |
---|---|---|---|---|---|
Fatty liver index | |||||
< 30 | 1570 | 5.3 | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) |
30–59 | 267 | 36.8 | 5.70 (4.98,6.53) | 3.53 (3.06,4.07) | 3.50 (2.99,4.10) |
≥ 60 | 147 | 62.4 | 9.96 (8.35,11.90) | 4.83 (3.99,5.84) | 4.19 (3.37,5.23) |
Body mass index ≥ 25 kg/m2 | |||||
No | 1413 | 4.9 | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) |
Yes | 571 | 25.9 | 4.52 (4.09,5.00) | 3.14 (2.83,3.49) | 3.01 (2.67,3.39) |
Waist circumference ≥ 85 cm | |||||
No | 1676 | 5.6 | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) |
Yes | 308 | 29.6 | 4.45 (3.92,5.04) | 2.89 (2.54,3.29) | 2.85 (2.46,3.30) |
Triglyceride ≥ 150 mg/dl or lipid lowering treatment | |||||
No | 1584 | 5.4 | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) |
Yes | 400 | 27.6 | 4.30 (3.84,4.81) | 2.82 (2.50,3.18) | 2.79 (2.44,3.20) |
Gamma-glutamyl transferase (GGT) highest quartile, ≥ 18 IU/L | |||||
No | 1007 | 4.3 | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) |
Yes | 977 | 12.9 | 2.78 (2.54,3.04) | 2.19 (2.00,2.40) | 2.22 (2.00,2.47) |